CuraTeQ Biologics receives approval for biosimilar Dazublys from UK's MHRA
Earlier in July 2025, Dazublys has received the marketing authorisation in the European Union from the European Commission
Earlier in July 2025, Dazublys has received the marketing authorisation in the European Union from the European Commission
Dr. Reddy’s becomes the first pharmaceutical company to receive regulatory approval to launch Linaclotide in India under the brand name Colozo
Mangalam Drugs and Organics receives repeat export order worth $ 21, 81,040
The suite represents a multi-million-dollar investment in equipment upgrades and enhancements to improve the site's capabilities
The AI system was tested on digital slides from breast, colon, stomach, and esophageal cancer cases
Projects 5X revenue growth by 2028, accelerates global market leadership and paves the way for IPO
This system enables comprehensive diagnosis of both acid and non-acid reflux, along with esophageal motility disorders.
The projected business potential is around US$ 1 million in the first year
Fourteenth breakthrough therapy designation granted by FDA across the oncology portfolio of Daiichi Sankyo
        Subscribe To Our Newsletter & Stay Updated